Prevention of nonsteroidal anti-inflammatory drug–associated gastrointestinal symptoms and ulcer complications
Author:
- 22 September 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine Supplements
- Vol. 117 (5) , 63-71
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysisClinical Therapeutics, 2004
- Esomeprazole provides effective control of NSAID-associated upper GI symptoms in patients continuing to take NSAIDsGastroenterology, 2003
- Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useGastroenterology, 2003
- Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleedingAlimentary Pharmacology & Therapeutics, 2002
- Upper gastrointestinal bleeding among users of NSAIDs: a population‐based cohort study in DenmarkBritish Journal of Clinical Pharmacology, 2002
- GASTROINTESTINAL SAFETY OF COX-2 SPECIFIC INHIBITORSGastroenterology Clinics of North America, 2001
- COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDsGastroenterology, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged swordArthritis & Rheumatism, 1995
- Mechanisms for Rapid Re-Epithelialization of the Gastric Mucosal SurfaceAnnual Review of Physiology, 1985